GLP-1 agonists like Ozempic come with a higher risk of severe GI issues than a different common weight-loss drug does.
from Livescience https://ift.tt/6vMa0GF
via IFTTT
Jumat, 06 Oktober 2023
Ozempic-like meds linked to higher risk of pancreatitis, 'stomach paralysis' than other weight-loss drugs
Related Posts:
How wealthy UFO fans helped fuel fringe beliefs- Mathematicians find 12,000 new solutions to 'unsolvable' 3-body problem
- Why do some people think cilantro tastes like soap?
- Maned wolf: A strikingly beautiful South American canid
- New mothers more likely to experience pareidolia, when your brain thinks it see faces in inanimate objects
0 komentar:
Posting Komentar